These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18756021)

  • 21. Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry.
    Chan W; Cui L; Xu G; Cai Z
    Rapid Commun Mass Spectrom; 2006; 20(11):1755-60. PubMed ID: 16676316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and mutagenicity of metabolites of aristolochic acid formed by rat liver.
    Schmeiser HH; Pool BL; Wiessler M
    Carcinogenesis; 1986 Jan; 7(1):59-63. PubMed ID: 3510750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low oxygen tension, as found in tissues in vivo, alters the mutagenic activity of aristolochic acid I and II in primary fibroblast-like rat cells in vitro.
    Maier P; Schawalder H; Weibel B
    Environ Mol Mutagen; 1987; 10(3):275-84. PubMed ID: 3678207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fermentation of Aristolochia debilis by six different medicinal fungi and identification of aristolochic acid derivates in their products by HPLC-ESI-TOF-MS.
    Liu X; Cao J; Pan Y; Zhang X
    Pak J Pharm Sci; 2018 May; 31(3):763-768. PubMed ID: 29716853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential comparison of genotoxic effects of aristolochic acid I and II in human cells by the mass spectroscopic quantification of γ-H2AX.
    Qu M; Xu H; Chen J; Xu B; Li Z; Ma B; Guo L; Ye Q; Xie J
    Toxicol In Vitro; 2022 Jun; 81():105349. PubMed ID: 35307501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic analysis of rhubarb extract by rat intestinal bacteria using liquid chromatography-tandem mass spectrometry.
    Song R; Xu L; Xu F; Dong H; Tian Y; Zhang Z
    Biomed Chromatogr; 2011 Mar; 25(3):417-26. PubMed ID: 21321975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
    Song Y; Yang X; Jiang Y; Tu P
    J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining in vivo dose-response curves for kidney DNA adduct formation of aristolochic acid I in rat, mouse and human by an in vitro and physiologically based kinetic modeling approach.
    Abdullah R; Wesseling S; Spenkelink B; Louisse J; Punt A; Rietjens IMCM
    J Appl Toxicol; 2020 Dec; 40(12):1647-1660. PubMed ID: 33034907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthesis and mass spectrometric analysis of aristolochic acid-deoxyguanosine adducts].
    Ji WX; Liu MX; Yang CD; Chen YP
    Yao Xue Xue Bao; 2008 Mar; 43(3):295-8. PubMed ID: 18630267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the oxidation of carcinogenic aristolochic acid I and II by microsomal cytochromes P450 in vitro: experimental and theoretical approaches.
    Martínek V; Bárta F; Hodek P; Frei E; Schmeiser HH; Arlt VM; Stiborová M
    Monatsh Chem; 2017; 148(11):1971-1981. PubMed ID: 29104318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the major metabolites of hyperoside produced by the human intestinal bacteria using the ultra performance liquid chromatography/quadrupole-time-of-flight mass spectrometry.
    Yang J; Qian D; Guo J; Jiang S; Shang EX; Duan JA; Xu J
    J Ethnopharmacol; 2013 May; 147(1):174-9. PubMed ID: 23458919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of new metabolites of morroniside produced by rat intestinal bacteria and HPLC-PDA analysis of metabolites in vivo.
    Li X; Huo C; Wang Q; Zhang X; Sheng X; Zhang L
    J Pharm Biomed Anal; 2007 Oct; 45(2):268-74. PubMed ID: 17707607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of aristolochic acid-RNA adducts in the urine of aristolochic acid-treated rats by liquid chromatography-tandem mass spectrometry.
    Leung EM; Chan W
    Chem Res Toxicol; 2015 Apr; 28(4):567-9. PubMed ID: 25715065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the DNA adducts induced by aristolochic acids in oligonucleotides by electrospray ionization tandem mass spectrometry.
    Chan W; Yue H; Wong RN; Cai Z
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3735-42. PubMed ID: 18973202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen.
    Pfau W; Schmeiser HH; Wiessler M
    Chem Res Toxicol; 1991; 4(5):581-6. PubMed ID: 1665354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
    Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
    Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitation of Protein Adducts of Aristolochic Acid I by Liquid Chromatography-Tandem Mass Spectrometry: A Novel Method for Biomonitoring Aristolochic Acid Exposure.
    Chan CK; Chan KJ; Liu N; Chan W
    Chem Res Toxicol; 2021 Jan; 34(1):144-153. PubMed ID: 33410325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid chromatography/mass spectrometry for metabonomics investigation of the biochemical effects induced by aristolochic acid in rats: the use of information-dependent acquisition for biomarker identification.
    Chan W; Lee KC; Liu N; Wong RN; Liu H; Cai Z
    Rapid Commun Mass Spectrom; 2008; 22(6):873-80. PubMed ID: 18288688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of aristolochic acid I after oral administration of Radix Aristolochiae or Guanxinsuhe preparation in canines.
    Yang HY; Zheng XH; Du Y; Chen Z; Zhu DY; Lou YJ
    J Ethnopharmacol; 2011 May; 135(2):569-74. PubMed ID: 21466839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.